Effects of ecabet sodium on experimentally induced reflux esophagitis

Journal of Gastroenterology

Volumn 35, Issue 7, 2000, Pages 504-509

  Omura, Nobuo ^a   Kashiwagi, Hideyuki ^a   Chen, Ganz ^a   Yano, Fumiaki ^a   Suzuki, Yutaka ^a   Aoki, Teruaki ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ecabet sodium; Gastric acid; Rats; Reflux esophagitis; Regurgitation

Indexed keywords

12 SULFODEHYDROABIETIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; ESOPHAGUS MUCOSA; HISTOPATHOLOGY; LAMINA PROPRIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REFLUX ESOPHAGITIS; SUBMUCOSA;

EID: 0033926668     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350070072     Document Type: Article

References (19)

1. 2 antagonists in the treatment of reflux esophagitis: a critical analysis. Am J Gastroenterol 1989;84: 245-8.
2. Maton PN. Omeprazole. N Engl J Med 1991;324:965-75.
3. Umeda N, Miki K, Hoshino E. Lansoprazole versus famotidine in symptomatic reflux esophagitis: a randomized, multicenter study. J Clin Gastroenterol 1995;20(Suppl 1):S17-23.
4. Baldi F, Bianchi PG, Dobrilla G, Iascone C, Lobello R, Marzio L, et al. Cisapride versus placebo in reflux esophagitis. J Clin Gastroenterol 1988;10:614-8.
5. Lepoutre L, Van Der Spek P, Vanderlinden I, Bollen J, Laukens P. Healing of grade-II and III oesophagitis through motility stimulation with cisapride. Digestion 1990;45:109-14.
6. Onoda Y, Magaribuchi T, Tamaki H. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new antiulcer agent, on gastric secretion and experimental ulcers in rats. Jpn J Pharmacol 1989;51:65-73.
7. Ito Y, Nakamura S, Onoda Y, Sugawara Y, Takaiti O. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. I. Inactivation of enzyme protein. Jpn J Pharmacol 1993;62: 169-74.
8. Ito Y, Sugawara Y, Takaiti O, Nakamura S. Metabolic fate of a new anti-ulcer drug (+)-(1R,4aS,10aR)-1,2,3,4,4a,9, 10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-1- phenanthrenecarboxylic acid 6-sodium salt pentahydrate (TA-2711). II. Distribution in the rat stomach. J Pharmacobiodyn 1991;14:547-54.
9. Kinoshita M, Yamasaki K, Kokusenya Y, Tamaki H. Relationship between gastroprotective effect of locally acting antiulcer agent ecabet sodium and its binding to gastric mucosa in rats. Comparison with sucralfate. Dig Dis Sci 1995;40:661-7.
10. Kinoshita M, Tamaki H. Possible mechanism of increase in gastric mucosal PGE2 and PGI2 generation induced by ecabet sodium, a novel gastroprotective agent. Dig Dis Sci 1997;42:83-90.
11. Omura N, Kashiwagi H, Aoki T. Changes in gastric hormones associated with gastric outlet obstruction. An experimental study in rats. Scand J Gastroenterol 1993;28:568-72.
12. Omura N, Kashiwagi H, Chen G, Suzuki Y, Yano F, Aoki T. Establishment of surgically induced chronic reflux esophagitis in rats. Scand J Gastroenterol 1999;34:948-53.
13. Nakamura K, Ozawa Y, Furuta Y, Miyazaki H. Effects of sodium polyacrylate (PANa) on acute esophagitis by gastric juice in rats. Jpn J Pharmacol 1982;32:445-56.
14. Inatomi N, Nagaya H, Takami K, Shino A, Satoh H. Effects of a proton pump inhibitor. AG-1749(lansoprazole), on reflux esophagitis and experimental ulcers in rats. Jpn J Pharmacol 1991;55: 437-51.
15. Kinoshita M, Saito N, Tamaki H. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats. Eur J Pharmacol 1997;321:325-32.
16. Ismail-Beigi F, Horton PF, Pope CE 2d. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970;58:163-74.
17. Behar J, Sheahan DC. Histologic abnormalities in reflux esophagitis. Arch Pathol 1975;99:387-91.
18. Bremner CG, Jeyasingham K. What are the limitations of the histological interpretation of a biopsy taken from the area of esophagitis? In: Giuli R, McCallum RW, editors. Benign lesions of the esophagus and cancer. Berlin Heidelberg New York Tokyo: Springer-Verlag; 1989. p. 148-53.
19. Robert HR. The biopsy diagnosis of gastroesophageal reflux disease, "carditis," and Barrett's esophagus, and sequelae of therapy. Am J Surg Pathol 1996;20(Suppl 1):S30-50.